METABOLIC PHARMACEUTICALS LIMITED
Forum - Small Caps - Stocks to Watch
MBP - Dr Roland Scollay, CEO
Mon, 8 May 2006 03:00PM
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Dr Roland Scollay
Mon, 8 May 2006
03:00PM Australia/NSW
Boardroom Radio Tools
Select a tab above to display more information
METABOLIC PHARMACEUTICALS LIMITED (MBP)
ASX code: MBP
Website: http://www.metabolic.com.au
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Metabolic Pharmaceuticals Limited is a Melbourne based, ASX listed biotechnology company. Metabolic’s focus is to take drug candidates through research, formal preclinical and clinical development. The Company is developing a platform for the oral delivery of existing injected peptide drugs. This platform has the potential to generate multiple internal projects as well as a variety of licensing
Address:
509 St Kilda Road, Level 3
MELBOURNE
VIC
Phone: 9860 5700
Fax: 9860 5777
Executives & Directors
Mr Rob Stewart , Non Exec. Chairman
Mr Don Clarke , Non Exec. Director
Mr Iain Kirkwood , Non Exec. Director
Mr Paul Lappin , Non Exec. Director
Mr Franklyn Brazil , Non Exec. Director
Ms Diana Attana (Assist.Co. Secretary) , Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
METABOLIC PHARMACEUTICALS LIMITED (MBP) Events
| Company (Stock Code) | Date/Time | Event | Timezone: Australia/NSW |
|---|---|---|---|
|
Fri, 2 Nov 2007 10:00AM |
MBP - 2007 Annual General Meeting - Dr Roland Scollay, CEO |
     |
|
|
Tue, 19 Dec 2006 02:00PM |
MBP - Metabolic Completes Options Study for Obesity Drug: AOD9604 - Dr Roland Scollay, CEO |
|
|
Mon, 30 Oct 2006 02:30PM |
MBP - Annual General Meeting - Dr Roland Scollay, CEO |
|
|
Mon, 8 May 2006 03:00PM |
Forum - Small Caps - Stocks to Watch MBP - Dr Roland Scollay, CEO |
|
| Thu, 27 Nov 2008 02:00PM 02:00PM Australia/Victoria |
Annual General Meeting Minter Ellison Lawyers, Level 23, 525 Collins St, Melbourne, VIC
|
||
| Thu, 21 Aug 2008 | Full Year Results | ||
| Wed, 27 Feb 2008 | Interim Results | ||
| Fri, 2 Nov 2007 10:00AM |
Annual General Meeting 452 Johnston Street Abbotsford VIC 3067
|
||
| Mon, 26 Feb 2007 | Interim Results | ||
| Fri, 27 Oct 2006 10:00AM |
Annual General Meeting Level 23, Rialto South Tower, 525 Collins Street Melbourne VIC 3000
|
||
| Mon, 28 Aug 2006 | Full Year Results | ||
| Mon, 27 Feb 2006 | Interim Results | ||
| Fri, 28 Oct 2005 10:00AM |
Annual General Meeting | ||
METABOLIC PHARMACEUTICALS LIMITED (MBP)
| Details of Company Address | Thu, 8 Jan 2009 |
| XCD: Metabolic Investment into PolyNovo | Thu, 18 Dec 2008 |
| Metabolic invests $3.5 million for 60% of PolyNovo | Thu, 18 Dec 2008 |
| Appendix 3B | Wed, 3 Dec 2008 |
| Proposed PolyNovo acquisition terminated | Mon, 1 Dec 2008 |
| Results of Meeting | Thu, 27 Nov 2008 |
| AGM Presentation | Thu, 27 Nov 2008 |
| Chairman AGM Address | Thu, 27 Nov 2008 |
| Appendix 3B | Fri, 31 Oct 2008 |
| Notice of Annual General Meeting/Proxy Form | Tue, 28 Oct 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
